Filter
3963
Filtered Results: 3963
Text search:
trial
Featured
Recommendations
397
New Publications
749
Language
Document type
No document type
2109
Guidelines
667
Studies & Reports
663
Manuals
193
Fact sheets
126
Strategic & Response Plan
83
Training Material
44
Situation Updates
25
Resource Platforms
23
Infographics
15
Brochures
8
Videos
5
App
1
Online Courses
1
Countries / Regions
India
191
Global
162
South Africa
89
Western and Central Europe
73
Kenya
72
Africa
60
Ethiopia
56
Sierra Leone
49
Nigeria
49
Uganda
49
Liberia
47
Russia
46
Malawi
44
Nepal
42
Germany
36
Eastern Europe
36
Zambia
35
Brazil
34
Latin America and the Carribbean
34
Tanzania
33
Bangladesh
32
Ukraine
32
East and Southern Africa
32
West and Central Africa
32
Ghana
27
Rwanda
27
Zimbabwe
26
South Sudan
25
Philippines
24
Indonesia
24
Congo, Democratic Republic of
22
Syria
21
Middle East and North Africa
21
South–East Asia Region
21
Mozambique
20
Asia
20
Myanmar / Burma
19
Guinea
18
Senegal
16
Cambodia
16
Burkina Faso
15
Lesotho
15
Namibia
14
Colombia
13
Paraguay
13
USA
12
Cameroon
11
Thailand
9
Argentina
9
Eastern Europe and Central Asia
9
Peru
8
Eswatini/ Swaziland
8
Venezuela
8
Vietnam
8
China
7
Sudan
7
Botswana
7
Angola
7
Chile
7
Yemen
7
Mali
6
Guinea-Bissau
6
Haiti
6
Western Pacific Region
6
Jordan
5
Lebanon
5
Central African Republic
5
Albania
5
Southern Africa
5
Laos
5
Tajikistan
5
Spain
5
Pakistan
4
Iraq
4
Benin
4
Bolivia
4
Georgia
4
North America
4
United Kingdom
4
Côte d’Ivoire / Ivory Coast
3
Morocco
3
Somalia
3
Afghanistan
3
Papua New Guinea
3
Ecuador
3
Sri Lanka
3
Estonia
3
Iran
3
Kyrgyzstan
3
Turkey
2
North Macedonia
2
Switzerland
2
Hungary
2
Burundi
2
Greece
2
Madagascar
2
Mexico
2
Poland
2
Kazakhstan
2
Jamaica
2
France
2
Tunisia
2
Portugal
2
Belarus
2
Saudi Arabia
1
Niger
1
Egypt
1
Chad
1
Gambia
1
Malaysia
1
Ireland
1
Singapore
1
Serbia
1
Croatia
1
Honduras
1
El Salvador
1
Guatemala
1
Other region
1
Bhutan
1
Armenia
1
Canada
1
Qatar
1
Bulgaria
1
Lithuania
1
Moldova
1
Gabon
1
Japan
1
Denmark
1
Belgium
1
Norway
1
Authors & Publishers
Publication Years
Category
Countries
1075
Clinical Guidelines
470
Public Health
251
Women & Child Health
223
Key Resources
93
Capacity Building
45
Pharmacy & Technologies
39
Toolboxes
Mental Health
500
COVID-19
490
HIV
407
TB
317
NTDs
148
NCDs
128
Ebola
118
Caregiver
107
AMR
94
Disability
79
Rapid Response
78
Planetary Health
76
Pharmacy
71
Refugee
52
Conflict
51
Global Health Education
42
Health Financing Toolbox
23
Cholera
21
Zika
18
Natural Hazards
17
Polio
14
Social Ethics
11
Specific Hazards
9
Health Financing
1
The paper provides the rationale for these recommendations, which are based on analyses of data from the TRACT trial.
The Global Programme to Eliminate Lymphatic Filariasis (LF) is using mass drug administration (MDA) of antifilarial medications to treat filarial infections, prevent disease and interrupt transmission. Almost 500 million people receive these medications each year. Clinical ...s have recently shown that a single dose of a triple-drug combination comprised of ivermectin, diethylcarbamazine and albendazole (IDA) is dramatically superior to widely used two-drug combinations for clearing larval filarial parasites from the blood of infected persons. A large mul-
ticenter community study showed that IDA was well-tolerated when it was provided as MDA. IDA was rapidly advanced from clinical trial to policy and implementation; it has the potential to accelerate LF elimination in many endemic countries.
Sleeping sickness is controlled by case detection and treatment but this often only reaches less than 75% of the population. Vector control is capable of completely interrupting HAT transmission but is not used because of expense. We conducted a full scale field ... of a refined vector control technology. From preliminary trials we determined the number of insecticidal tiny targets required to control tsetse populations by more than 90%. We then carried out a full scale, 500 km2 field trial covering two HAT foci in Northern Uganda (overall target density 5.7/km2). In 12 months tsetse populations declined by more than 90%. A mathematical model suggested that a 72% reduction in tsetse population is required to stop transmission in those settings. The Ugandan census suggests population density in the HAT foci is approximately 500 per km2. The estimated cost for a single round of active case detection (excluding treatment), covering 80% of the population, is US$433,333 (WHO figures). One year of vector control organised within country, which can completely stop HAT transmission, would cost US$42,700. The case for adding this new method of vector control to case detection and treatment is strong. We outline how such a component could be organised.
DOI: 10.5772/intechopen.102891Little progress has been made since the 1960s and 19. 70s to widen the therapeutic arsenal against Trypanosoma cruzi, the causative pathogen of Chagas disease, which remains a frustrating and perplexing infectious disease. This chapter focuses on the strategic and opera...
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmanias...
Manufacturers:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
Efficacy shown in clinical trials in participants w...
May 9, 2022.Since the onset of the COVID-19 pandemic, a large number of clinical trials have been planned and developed to assess the effectiveness and safety of various interventions that could prevent hospitalizations and progression to severe dis...
WHO strongly recommends discontinuation of the nerve tissue vaccine, and replacement with modern concentrated and purified cell culture derived vaccines (CCDV) and embryonated eggbased rabies vaccines.
These vaccines must comply with WHO criteria for potency and innocuity following satisfactory ass...
The pharmacological treatment of heart failure has evolved over the last three decades since the demonstration of the effect of angiotensinconverting enzyme inhibitors on major cardiovascular events in patients with heart failure with reduced ejection fraction. Composite analysis of heart failure wi...
Medicines and Allied Substances [No. 3 of 2013 47 | An Act to continue the existence of the Pharmaceutical Regulatory Authority and re-name it as the Zambia Medicines Regulatory Authority; provide for the functions and powers of the Authority; provide for the registration and regulation of pharmacie...
The International Classification of Functioning, Disability and Health, known more commonly as ICF, provides a standard language and framework for the description of health and health-related states. Like the first version published by the World Health Organization for ... purposes in 1980, ICF is a multipurpose classification intended for a wide range of uses in different sectors. It is a classification of health and health-related domains -- domains that help us to describe changes in body function and structure, what a person with a health condition can do in a standard environment (their level of capacity), as well as what they actually do in their usual environment (their level of performance).
These domains are classified from body, individual and societal perspectives by means of two lists: a list of body functions and structure, and a list of domains of activity and participation. In ICF, the term functioning refers to all body functions, activities and participation, while disability is similarly an umbrella term for impairments, activity limitations and participation restrictions. ICF also lists environmental factors that interact with all these components.
Clinical management standard operating procedures.
Ebola virus disease (EVD) is a life-threatening multisystem illness associated with fever and gastrointestinal (GI) symptoms that frequently leads to hypovolaemia, metabolic acidosis, hypoglycaemia, and multi-organ failure. The prolonged 2013–201...
Wits Reproductive Health and HIV Institute (Wits RHI) is involved in an effort to curb the COVID-19 pandemic that is facing South Africa and the world at large. Prof. Helen Rees is a member of the team advising the Health Minister on COVID-19 (MAC). She is part of the Clinicians Group, the Research ...
This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public media. Although there are now ongoing clinical ...s testing the efficacy and safety of several medicines for COVID-19, as of the date of this document, there is a lack of quality evidence to demonstrate chloroquine and/or hydroxychloroquine are effective in the treatment of COVID-19. Evidence is recently emerging via small studies with sub-optimal methodologies that are conflicting.
High levels of storage iron may increase malaria susceptibility. This risk has not been investigated in semi-immune adolescents. We investigated whether baseline iron status of nonpregnant adolescent girls living in a high malaria transmission area in Burkina Faso affected malaria risk during the fo...
Early data from US biotech Moderna has revealed that its Covid-19 vaccine candidate is 94.5 per cent effective, raising hopes that a range of immunisations will be available to help end the pandemic.
The interim analysis of the vaccine, currently known as mRNA-1273, comes after 95 ... participants contracted Covid-19, including just five who were given the coronavirus jab.
A living WHO guideline on drugs for covid-19
recommended
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379
Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update number and date of access for clarity. The publication of the RE...
BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc...
Human African trypanosomiasis (HAT), or sleeping sickness, is a painful and protracted disease transmitted through the bite of infected tsetse flies and it is found in rural parts of sub-Saharan Africa. Sleeping sickness has two clinical phases but this review focuses only on treatment of the second...
Chromoblastomycosis (CMB) is a chronic fungal infection of the skin and the subcutaneous tissue caused by a transcutaneous traumatic inoculation of a specific group of dematiaceous fungi occurring mainly in tropical and subtropical zones worldwide. If not diagnosed at early stages, patients with CBM...
